Argent BioPharma (ASX: RGT) (OTCQB: RGTLF), a clinical-stage pharmaceutical company, is capturing the attention of investors as its groundbreaking epilepsy treatment, CannEpil®, gains momentum.
With President Donald Trump's recent announcement of sweeping tax policies on imported goods, there is much conversation about the impact on the U.
Foodnourish.net, a leading health and wellness platform, has published an extensive compilation of 80 fascinating food facts, offering readers evidence-based insights into everyday foods.
AquaterreX has unveiled an innovative approach to combating California wildfires by deploying "Natural Fire Hydrants" in fire-prone areas. These strategically placed water wells, combined with advanced Deep Seated Water technology, offer an immediate and sustainable water source to suppress wildfires and protect communities.
The U.S. Food & Drug Administration (FDA) has granted Lumitron Technologies, Inc. the designation of “Breakthrough Device” for its HyperVIEWTM X-Ray system utilizing the K-Edge subtraction technique to enable contrast-enhanced imaging for diagnosis of breast cancer.
Diag-Nose.io, a trailblazer in biotechnology and a distinguished graduate from Stanford University’s EENT Innovation Biodesign program, proudly announces the closure of an oversubscribed $2M seed funding round.
PowerPatent, a pioneer in intellectual property solutions, has announced the launch of its groundbreaking Solutions for Wireless Communication Patents at the prestigious Global Telecom IP Forum.
